Michael Greeley - Profile and Investment Details

Investor Profile

Michael Greeley is a Venture Capital, Founder, Private Equity Firm, Investor based in Boston, Massachusetts, United States with a diverse investment portfolio that includes companies such as Springleaf Therapeutics, Magen BioSciences, Oshi Health, Aspen RxHealth, Circulation, HealthReveal, RightMove Health, Cohere Health, Aetion, T2 Biosystems, Suki, LuminDx, Rock Health, Cayaba Care, Lighter LivingEarlyBird, Somatus, Bright Health, Functional Neuromodulation, Welltok, Inc., GCC Investments, Nuvesse (PolyRemedy), Predilytics, National Venture Capital Association, TARIS Biomedical, MicroCHIPS, Axuall, Inc., Predictive Biosciences, BlueTarp Financial, HealthVerity, Iora Health, Protein Forest, Inc., Valence Health, Eden Health, Author Health, VisitPay, Curisium, Protein Forest, The ADA Forsyth Institute, Explorys, Inc., PolyRemedy, VidSys, Inc., ClearDATA, Higi, Circulation, Inc., Oui Health, UnifiHealth, Tausight, Inbound Health, Welltok, . Over time, Michael Greeley has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Michael Greeley is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Medication Adherence, Healthcare Delivery, Wellness, Women Founded, Infrastructure, Apps, Healthcare Innovation, Telemedicine, Life Science, Engineering, Education, Artificial Intelligence (AI), Information Technology (IT), Analytics, Mobile, Software, Biotechnology, Electronic Health Records (EHR), Health and Hospital Services, Clinical Trials, Employee Benefits, Consumer Internet, Consumer Software, Home Care, Insurance, Telehealth, Digital Health, Medical, Information Technology, B2B, Health Tech, Healthcare Payments, Women’s Health, Machine Learning, Personal Health, Pharmaceuticals, Healthcare Technology, Mental Health may find it worthwhile to explore potential connections with Michael Greeley, as their portfolio suggests a familiarity and interest in this area.

Understanding Michael Greeley’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.